Market Highlights and Key Updates for January 23
The market is buzzing with activity as several major stocks announce their quarterly earnings today. Investors are keenly watching for results from stocks like UltraTech Cement, Dr. Reddy’s Laboratories, Hindustan Petroleum Corporation, Indus Towers, United Spirits, Adani Energy Solutions, Adani Green Energy, Amber Enterprises India, Capri Global Capital, Cyient, Greaves Cotton, Indian Energy Exchange, KFin Technologies, Mankind Pharma, Mphasis, Nippon Life India Asset Management, Senores Pharmaceuticals, Sona BLW Precision Forgings, Spandana Sphoorty Financial, Suryoday Small Finance Bank, Syngene International, Tejas Networks, Thyrocare Technologies, Ujjivan Small Finance Bank, V2 Retail, and Zee Entertainment Enterprises.
Quarterly Earnings Highlights
Hindustan Unilever (HUL) Q3 (Standalone YoY)
- Profit: ₹3,001 crore (+19.1%)
- Revenue: ₹15,408 crore (+1.4%)
- EBITDA: ₹3,570 crore (+0.8%)
- Margins: Slight dip to 23.2% from 23.3%
- Key Approvals:
- Demerger of ice cream business, Kwality Wall’s (India).
- Acquisition of Vishwatej Oil Industries’ palm unit as part of HUL’s palm localization strategy.
- 90.5% stake acquisition in Uprising Science for ₹2,670 crore.
Bharat Petroleum Corporation (BPCL) Q3 (Standalone QoQ)
- Profit: ₹4,649.2 crore (+93.9%)
- Revenue: ₹1,13,135.8 crore (+10.1%)
- EBITDA: ₹7,580.4 crore (+68%)
- Margin Expansion: 6.7% from 4.4%
- Key Developments:
- Formation of a joint venture with Praj Industries for setting up compressed bio-gas plants across India.
- Development plan submission for the Indonesian Nunukan oil and gas block.
Persistent Systems Q3 (Consolidated QoQ)
- Profit: ₹373 crore (+14.8%)
- Revenue: ₹3,062.3 crore (+5.7%)
Pidilite Industries Q3 (Consolidated YoY)
- Profit: ₹557 crore (+9%)
- Revenue: ₹3,368.9 crore (+7.6%)
Gravita India Q3 (Consolidated YoY)
- Profit: ₹78 crore (+29.3%)
- Revenue: ₹996.4 crore (+31.5%)
Cigniti Technologies Q3 (Consolidated YoY)
- Profit: ₹63.6 crore (+32.3%)
- Revenue: ₹516.4 crore (+10.3%)
Go Digit General Insurance Q3 (YoY)
- Gross Written Premium: ₹2,677 crore (+10.3%)
- Profit: ₹119 crore (+176.7%)
- Assets Under Management (AUM): ₹18,939 crore (+27%)
Stocks to Watch
- Laurus Labs: US FDA conducted a four-day inspection of its subsidiary in New Jersey, focusing on adverse drug reporting practices for its stocks of marketed products.
- Paras Defence: Signed an MoU with the Maharashtra government for a ₹12,000 crore Optics Park Project in Navi Mumbai, expected to begin in 2028.
- Piramal Pharma: Launched Chlorpromazine Hydrochloride injection in the U.S. for treating schizophrenia and other disorders, adding to its pharmaceutical stocks.
- Shiva Cement: Planning a ₹380 crore cement grinding unit at Bhushan Power’s premises in Sambalpur.
- Effwa Infra & Research: Secured a $4.29 million export order for upgrading the drinking water system in Ivory Coast.
Other Updates
- Mainboard Listing: Stallion India Fluorochemicals (January 23).
- SME Listing: Landmark Immigration Consultants (January 23).
- Stock Ex-Date for InvIT Income Distribution: Property Share Investment Trust.
This active day in the market sees significant focus on company performance and developments, highlighting numerous stocks with potential opportunities for investors. Keep an eye on sector-specific trends and stocks with strong fundamentals for better portfolio decisions.
Stocks to Watch
- Laurus Labs: US FDA conducted a four-day inspection of its subsidiary in New Jersey, focusing on adverse drug reporting practices.
- Paras Defence: Signed an MoU with the Maharashtra government for a ₹12,000 crore Optics Park Project in Navi Mumbai, expected to begin in 2028.
- Piramal Pharma: Launched Chlorpromazine Hydrochloride injection in the U.S. for treating schizophrenia and other disorders.
- Shiva Cement: Planning a ₹380 crore cement grinding unit at Bhushan Power’s premises in Sambalpur.
- Effwa Infra & Research: Secured a $4.29 million export order for upgrading the drinking water system in Ivory Coast.
- Jupiter Wagons: The board will consider fund-raising options on January 29.
- Sanofi India: Received a ₹26.5 crore transfer pricing order for AY 2022-23.
Listings and Other Developments
- Mainboard Listing: Stallion India Fluorochemicals (January 23).
- SME Listing: Landmark Immigration Consultants (January 23).
- Stock Ex-Date for InvIT Income Distribution: Property Share Investment Trust.
The day is set to be action-packed with key earnings reports and developments that could drive market sentiment. Investors are advised to monitor sector-specific trends and stock-specific movements closely.
